Overview
Arctop has developed a neural decoding platform that translates raw EEG signals from any compatible headset into standardized cognitive and emotional metrics via a cloud API. Their technology enables third-party applications to integrate personalized brain-adaptive experiences without custom hardware.
Arctop is a Los Angeles-based neurotechnology company operating at the intersection of brain-computer interfaces and consumer software. The company has developed a neural decoding platform that processes raw EEG signals from commercially available headsets and translates them into standardized cognitive and emotional metrics. These metrics are delivered to developers and enterprises through a cloud-based API, removing the need for proprietary hardware or deep neuroscience expertise on the part of integrators. By abstracting the complexity of brain signal interpretation into a clean software layer, Arctop effectively functions as the infrastructure layer for brain-adaptive applications.
Arctop has raised $5 million in seed funding, reflecting early investor confidence in its platform approach to neural data interpretation. The company's hardware-agnostic model positions it uniquely within the BCI landscape, where most competitors remain vertically integrated around proprietary device ecosystems. By enabling any compatible EEG headset to serve as an input device, Arctop significantly lowers the barrier to entry for third-party developers building personalized, brain-responsive experiences. This approach allows the company to scale its technology across industries including entertainment, wellness, gaming, and enterprise productivity without being constrained by device manufacturing timelines or costs.
Arctop represents a meaningful shift in how the neurotech industry thinks about commercialization and accessibility. Rather than requiring end users to adopt new hardware, the platform meets the market where it already exists, accelerating real-world deployment of brain-computer interface technology. This model also positions Arctop to accumulate a broad and diverse dataset of neural signals across populations, which could compound the accuracy and personalization of its decoding algorithms over time. As the BCI industry matures, infrastructure-layer companies like Arctop may prove essential in bridging the gap between raw neuroscience research and scalable consumer and enterprise applications.
More in Brain-Computer Interfaces
Latest industry news
Synchron Closes $275M Series D to Accelerate Stentrode BCI Commercialization
2026-06-15 · Funding
MIT Researchers Demonstrate Real-Time Emotion Decoding via Non-Invasive EEG with 94% Accuracy
2026-06-13 · Research
Synchron Launches Stentrode Home Edition, Expanding BCI Access Beyond Clinical Settings
2026-06-11 · Product
Synchron Reaches 100-Patient Milestone as Stentrode BCI Moves Toward Pivotal Trial
2026-06-09 · Industry
Company details
Category
🧠 Brain-Computer Interfaces
Location
Los Angeles, USA
Funding
Seed · $5M
Website
arctop.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →